The global enteral feeding devices market size was valued at USD 4.3 billion in 2023 and is projected to grow at a compound annual growth rate (CAGR) of 5.0% from 2024 to 2030. Growing geriatric population has resulted in increased incidences of diabetes, severe pancreatitis, and other gastrointestinal diseases, which aids market growth. Adoption of the “Feed Early Enteral Diet Adequately for Maximum Effect” (FEED ME) protocol in surgical trauma ICUs in the U.S. enables subsidies on these devices. Technological advancements such as the introduction of tri-funnel replacement G-tubes and J-tubes with reverse balloon designs are also expected to aid in growth during the forecast period.
Numerous NCBI studies suggest that people over 65 years pose a higher risk of developing chronic illnesses including Parkinson’s and nervous system disorders. The global population aged 60 years and older is expected to increase from around 1 billion in 2020 to about 1.4 billion in 2030 and is expected to double by 2050 to reach around 2.1 billion. The number of elderly patients with critical illnesses has increased significantly over the past few years. The risk of malnutrition and frailty among the geriatric population with comorbidities, such as stroke, depression, and dementia, is much higher, mainly owing to various age-related changes in body composition and muscle mass. This results in a reduced ability to perform Activities of Daily Living (ADLs), thereby increasing the risk of falls or injuries.
Gather more insights about the market drivers, restrains and growth of the Global Enteral Feeding Devices Market
Product Insights
Based on products, the enteral feeding pump segment dominated the market in 2023 with a 50.8% share as these pumps are designed for safer & more intuitive nutritional care. Enteral feeding is the process of delivering nutrients directly to the stomach through a tube, and the tube is connected to an electric pump. Growing healthcare infrastructure and technological advancements in medical devices segment are expected to drive market growth. Technological advancements such as introduction of compact, reliable, and easy-to-use devices, such as Kangaroo ePump developed by Covidien, are expected to boost the demand for enteral feeding pumps during the forecast period.
Age Group Insights
The adult age group segment dominated the market with a revenue share of 91.3% in 2023. A published paper in NCBI stated that approximately 70-80% of pregnant women suffer from nausea and vomiting during pregnancy. In such cases, enteral nutrition is used to prevent adverse conditions, including fetal intrauterine growth restriction, preterm infant birth incidents, and maternal dehydration.
Indication Insights
Based on indication, the cancer care segment dominated the market with a revenue share of 27.9% in 2023. Enteral feeding can be used in critically ill patients for many other diseases and conditions, such as COPD, cystic fibrosis, and respiratory disorders. For instance, Pulmocare, an Abbott product, is used as an enteral feed for treatment of these conditions. Conditions such as inflammation, postoperative stress, and infections can also be treated with the help of enteral feeds.
End-use Insights
Based on end-use, hospitals dominated the market with a 58.3% market share in 2023. Growing awareness among healthcare professionals and others regarding hospital-associated malnutrition is one of the significant factors expected to boost the use and demand for enteral feeding devices in hospitals. Moreover, increasing number of ICU admissions & re-admissions, increasing demand for enteral foods & formulations among critically or severely ill patients, and rising prevalence of several chronic disorders such as diabetes, cancer, & others are some of the major factors that drive the market growth.
Browse through Grand View Research's Healthcare Industry Research Reports.
· Rehabilitation Equipment Market: The global rehabilitation equipment market size was estimated at USD 16.96 billion in 2024 and is projected to grow at a CAGR of 8.3% from 2025 to 2030.
· ADME Toxicology Testing Market: The global ADME toxicology testing market size was estimated at USD 6.38 billion in 2024 and is projected to witness a CAGR of 10.0% from 2025 to 2030.
Regional Insights
North America held the largest market share of 37.2% in 2023. Growing number of premature infants in critical care is a major factor driving the regional market growth. For instance, according to CDC, about 1 in 10 babies was born prematurely in the U.S. in 2021. The market is significantly driven by increase in geriatric population, which is more susceptible to chronic diseases that result in various disorders such as gastrointestinal disorders, metabolic disorders, and neurological disorders.
Key Companies & Market Share Insights
The market players are focusing on product development, new technological advancements, and other initiatives to strengthen their market position.
Key Enteral Feeding Devices Companies:
· Conmed Corporation
· C.R.Bard
· Cook Medical
· Boston Scientific Corporation
· Moog Inc.
· Fresenius Kabi AG
· Danone Medical Nutrition
· Kimberly-Clark
· Abbott Nutrition
· B Braun Melsungen AG
· Avanos Medical, Inc.
· Cardinal Health
· Applied Medical Technology, Inc.
· Vygon India
· Fidmi Medical
· ALCOR Scientific
· Amsino International, Inc.
Order a free sample PDF of the Enteral Feeding Devices Market Intelligence Study, published by Grand View Research.
